Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Cockwell

Showing results (141-150 of 190) with videos related to

Pageof 19
Sort By:
BMJ Open|October 31, 2018
Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocolDerek Kyte, Jon Bishop, Elizabeth Brettell, et al.
Kidney International|April 15, 2011
CD248+ stromal cells are associated with progressive chronic kidney diseaseStuart W Smith, Kevin S Eardley, Adam P Croft, et al.
Hypertension (Dallas, Tex. : 1979)|January 13, 2016
Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney DonorsWilliam E Moody, Charles J Ferro, Nicola C Edwards, et al.
American Journal of Nephrology|April 10, 2026
Potentially modifiable factors associated with longitudinal health-related quality of life in the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohortThomas Phillips, Scott Harris, Olalekan Lee Aiyegbusi, et al.
Kidney International|September 12, 2008
Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammationDaniel Zehnder, Marcus Quinkler, Kevin S Eardley, et al.
Clinical Endocrinology|October 26, 2018
Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross-sectional studyMichael S Sagmeister, Angela E Taylor, Anthony Fenton, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 5, 2026
Sex Associated Biomarker Differences in Chronic Kidney Disease Progression and MortalityThomas McDonnell, Anthony Onoja, Nicolas Vuilleumier, et al.
British Journal of Haematology|January 8, 2025
Diagnosis and management of monoclonal gammopathy of renal significance: A British Society for Haematology good practice paperJennifer Pinney, Candice Roufosse, Andreas Kousios, et al.
Journal of the American Society of Nephrology : JASN|April 23, 2011
Early reduction of serum-free light chains associates with renal recovery in myeloma kidneyColin A Hutchison, Paul Cockwell, Stephanie Stringer, et al.
Clinical Kidney Journal|February 5, 2024
Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohortThomas Phillips, Scott Harris, Olalekan Lee Aiyegbusi, et al.
Pageof 19

Showing results (141-150 of 190) with videos related to

Sort By:
Pageof 19
BMJ Open|October 31, 2018
Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocolDerek Kyte, Jon Bishop, Elizabeth Brettell, et al.
Kidney International|April 15, 2011
CD248+ stromal cells are associated with progressive chronic kidney diseaseStuart W Smith, Kevin S Eardley, Adam P Croft, et al.
Hypertension (Dallas, Tex. : 1979)|January 13, 2016
Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney DonorsWilliam E Moody, Charles J Ferro, Nicola C Edwards, et al.
American Journal of Nephrology|April 10, 2026
Potentially modifiable factors associated with longitudinal health-related quality of life in the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohortThomas Phillips, Scott Harris, Olalekan Lee Aiyegbusi, et al.
Kidney International|September 12, 2008
Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammationDaniel Zehnder, Marcus Quinkler, Kevin S Eardley, et al.
Clinical Endocrinology|October 26, 2018
Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross-sectional studyMichael S Sagmeister, Angela E Taylor, Anthony Fenton, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 5, 2026
Sex Associated Biomarker Differences in Chronic Kidney Disease Progression and MortalityThomas McDonnell, Anthony Onoja, Nicolas Vuilleumier, et al.
British Journal of Haematology|January 8, 2025
Diagnosis and management of monoclonal gammopathy of renal significance: A British Society for Haematology good practice paperJennifer Pinney, Candice Roufosse, Andreas Kousios, et al.
Journal of the American Society of Nephrology : JASN|April 23, 2011
Early reduction of serum-free light chains associates with renal recovery in myeloma kidneyColin A Hutchison, Paul Cockwell, Stephanie Stringer, et al.
Clinical Kidney Journal|February 5, 2024
Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohortThomas Phillips, Scott Harris, Olalekan Lee Aiyegbusi, et al.
Pageof 19